Ten finalists named for 2024 European Prize for Women Innovators

Brussels, February 20th 2024
Summary
  • The European Innovation Council and the European Institute of Innovation and Technology announced ten finalists for the 2024 European Prize for Women Innovators.
  • Winners across three categories will be revealed at the R&I Week opening on 18 March 2024.
  • The joint EIC and EIT prize awards cash prizes and visibility but will not on its own remove systemic barriers to scaling women-led deep tech companies.
  • Finalists include founders working across space propulsion, clinical voice AI, medtech to reduce cancer treatment side effects, paediatric exoskeletons and targeted nanomedicines.
  • EIT analysis with Dealroom suggests women-founded tech scale-ups grew 1.2 times faster than peers and increased valuation by 6.5 times over five years, underlining the potential economic upside of greater inclusivity.

European Prize for Women Innovators 2024: finalists, categories and context

On 20 February 2024 the European Innovation Council and the European Institute of Innovation and Technology announced the ten finalists for the 2024 European Prize for Women Innovators. The announcement was made at the EIT Summit. The competition is being run jointly by the EIC and the EIT and will award winners at the opening of Research and Innovation Week on 18 March 2024. The move formalises closer cooperation between two of the EU's main innovation support bodies to raise visibility of women founders and leaders in technology and innovation.

European Commissioner Iliana Ivanova offered congratulations to the finalists and singled out projects ranging from alternatives to conventional food systems to medical technology for cancer care. Her statement highlighted the role of role models in encouraging more women to pursue careers in innovation.

How the prize is structured

The joint EIT and EIC prize is split across three categories. The awards combine cash prizes with publicity and network access. The prize is explicitly framed to increase the visibility of women founders and leaders and to create additional role models for girls and women considering careers in STEM and entrepreneurship.

CategoryWho is eligiblePrizes
Women InnovatorsWomen founders and co-founders across EU Member States and Horizon Europe associated countriesEUR 100 000 for the winner, EUR 70 000 and EUR 50 000 for two runners-up
Rising InnovatorsPromising women innovators under the age of 35EUR 50 000 for the winner, EUR 30 000 and EUR 20 000 for two runners-up
EIT Women LeadershipExceptional women members of the EIT CommunityEUR 50 000 for the winner, EUR 30 000 and EUR 20 000 for two runners-up

The ten finalists

The finalists announced cover a range of sectors from space hardware to medtech, biotech, circular packaging, sustainable food and transport. Below is a compact roster of the shortlisted women, their countries and a one line description of their innovation as presented by the EIT and EIC.

FinalistCountryRole and organisationShort descriptionCategory
Sara Correyero PlazaSpainCEO and Co-Founder, IENAI SPACEDevelops and manufactures electric propulsion modules for nanosatellites together with mission optimisationRising Innovators
María González MansoSpainCEO and Co-Founder, tucuviAutomates follow-up phone consultations with empathetic artificial intelligenceRising Innovators
Bàrbara OliveiraIrelandCTO and Co-Founder, Luminate MedicalDevelops technology to help prevent side effects of cancer treatmentRising Innovators
Eva SadounFranceCEO and Co-Founder, Lita.coPlatform to make it easier to invest in social enterprisesRising Innovators
Elena García ArmadaSpainCEO and Co-Founder, Marsi BionicsDevelops paediatric exoskeletons and robotic kneesWomen Innovators
Rana SanyalTürkiyeCSO and Co-Founder, RS ResearchDevelops smart nanomedicines for targeted chemotherapyWomen Innovators
Natalia TomiyamaGermanyManaging Director and Co-Founder, NÜWIELDevelops electric trailers that can match the movement of the pedestrian or biker pulling itWomen Innovators
Yuliia BialetskaUkraine/EstoniaCEO and Co-Founder, S.labDevelops alternatives to plastic foam packagingEIT Women Leadership
Deniz FiciciogluGermanyManaging Director and Co-Founder, BettaF!sh GmbHDevelops seaweed-based alternatives to fishEIT Women Leadership
Cristina PurtillIrelandCEO, Plio SurgicalDeveloped a magnetic solution to support intestinal post-surgery recoveryEIT Women Leadership

Explaining some of the technologies and business models

Electric propulsion for nanosatellites:IENAI SPACE builds compact electric thrusters that enable small satellites to perform orbit changes, station keeping and deorbiting. Electric propulsion typically offers higher specific impulse than chemical systems which improves propellant efficiency. For nanosatellites the engineering trade-off is between power consumption, thrust level and mass. Commercial adoption depends on reliability, integration with satellite platforms and regulatory approvals for launches and operations.
Clinical voice AI for patient follow-up:Tucuvi deploys an automated voice agent to conduct phone-based clinical follow-up. Voice AI systems in clinical settings must combine robust natural language processing, evidence-based clinical protocols and strict data protection. Adoption requires clinical validation, regulatory compliance where the tool is used as a medical device and careful monitoring for errors and bias in automated triage or escalation decisions.
Medtech to prevent chemotherapy side effects:Luminate Medical focuses on interventions that reduce the incidence or severity of common chemotherapy side effects. Technologies in this space range from topical and device-based approaches to adjunct therapies that need clinical trials to demonstrate benefit on patient reported outcomes and on health economic endpoints such as reduced hospital visits.
Paediatric exoskeletons and variable stiffness actuation:Marsi Bionics develops exoskeletons designed for children. Contemporary designs often use variable stiffness actuators to replicate some behaviours of human muscle and to provide adaptive assistance. Clinical deployment requires device safety, validated rehabilitation protocols and pathways for reimbursement in health systems.
Targeted nanomedicines:RS Research works on nanocarrier systems that aim to concentrate chemotherapy in tumours while sparing healthy tissue. Nanomedicine promises better therapeutic indexes but faces complex development pathways including manufacturing at GMP quality, toxicity testing and large clinical trials to show improved outcomes compared to standard formulations.
Electric cargo trailers for last mile logistics:NÜWIEL supplies powered trailers meant to replace small delivery vans for certain use cases. The key technical and commercial considerations are how the trailers interface with bicycles and e-bikes, their handling safety in mixed traffic, battery life, maintenance and whether they reduce total emissions after full lifecycle assessment.
Alternatives to foam packaging and seaweed-based food:S.lab works on sustainable packaging that replaces expanded polystyrene foam with compostable or recyclable formulations. BettaF!sh is developing seaweed-derived substitutes to fish that aim to reduce pressure on marine stocks. Both categories are subject to consumer acceptance tests, cost and scaling challenges and regulatory checks on food safety.
Magnetic anastomosis implant:Plio Surgical has developed a magnetic implant that assists the reconnection of intestinal tissue after resection. The technology aims to reduce leak rates, a key post-operative complication. Clinical benefit needs to be demonstrated across trials and adoption depends on surgical workflow integration, regulatory approval and reimbursement.

Why the prize matters and what it does not solve

The prize is primarily an instrument for visibility, role modelling and networking. Cash awards matter, particularly to early stage teams, but they are not a substitute for follow-up financing, procurement adoption, regulatory support and market access. The EIC and EIT provide other instruments such as grants, acceleration services and co-investment channels that can be decisive in a company’s path to scale.

The EIT has highlighted data produced with Dealroom that points to stronger growth among women-founded tech scale-ups. The study reported that women-founded tech scale-ups increased their valuation 6.5 times and grew 1.2 times faster than peers over a five year period. Those figures argue that inclusion can boost European innovation performance. At the same time the broader EIT research shows low female representation among founders in the scale-up cohort. Awards help address perception and role model gaps but systemic inequalities in venture funding, procurement and corporate procurement remain.

The joint EIT and EIC prize is one element in a wider set of EU measures aiming to support inclusive innovation. The agencies position the prize as a way to connect nominees into networks, normalise women in leadership and to inspire more women and girls to enter STEM and entrepreneurship. Since the first edition launched in 2011, more than 30 women have received the EU Prize for Women Innovators and over 100 have been shortlisted, producing a body of role models and case studies.

What to watch next

Winners will be announced on 18 March 2024 at the opening of R&I Week. Beyond the ceremony, the practical indicators of impact to watch are follow-on funding raised by winners and finalists, clinical trial progress where relevant, product market entry and whether the prize concretely improves access to procurement, pilot customers and institutional contracts. If the award leads to measurable acceleration in those areas it will have delivered more than a headline moment.

For journalists, investors and policy watchers, the shortlist is a useful indicator of the types of deep tech and mission oriented projects attracting attention in the EU innovation ecosystem. For policymakers the shortfall remains the structural work of improving capital access, public procurement for innovation and support for regulatory pathways that take promising prototypes into mainstream care or industry.

Practical information

More information on the prize, the rules and previous winners is published by the European Innovation Council and the European Institute of Innovation and Technology. The prize is managed by the EISMEA agency which implements the EIC programmes and coordinates with EIT communities.